Document is current
Any future updates will be listed below
-
Authors
Straburzyński, Marcin
Kopyt, Daria
Marschollek, Karol
Błaszczyk, Bartłomiej
Kuca-Warnawin, Ewa
Kurowska, Weronika
Misiak, Błażej
Peng, Kuan-Po
Waliszewska-Prosół, Marta
May, Arne
-
Funding
Funding for this research was provided by:
University of Warmia and Mazury in Olsztyn
Funded by the Minister of Science under'the regional Initiative of Excellence Program'
- License Information
-
More Information
Article History
Received: 23 March 2025
Accepted: 17 April 2025
First Online: 25 April 2025
Declarations
:
: Not applicable.
: Not applicable.
: MS reports personal fees from Pfizer, Teva, Bausch, AbbVie, Neuca and Novartis for speaker activities. DK reports no competing interests. KM reports no competing interests. BB reports no competing interests. EKW reports no competing interests. WK reports no competing interests. BM reports no competing interests. KPP reports no competing interests. MW-P is member of Editorial Board: The Journal of Headache and Pain; reports personalfees from Abb. Vie, Pfizer, Polpharma and Teva for speaker activities. AM reports personal fees from Novartis, Betapharm, TEVA and Ipsen for speaker activities or advisory boards.
